SIMULTANEOUS endometrial aspiration and sonohysterography offer a highly sensitive screening approach for detecting ...

The INTERLACE trial has revealed that adding short-course induction chemotherapy to chemoradiotherapy significantly improves ...

To facilitate further research, the EMBL team released the Microbial Load Predictor (MLP) tool, which is freely available for ...

Isabel A Hujoel, University of Washington, USA, explained that given the known potential of ARBs to cause enteropathy ...

Discover a study where findings suggest that priority should be placed on identifying and managing autoimmune and ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

Discover how machine learning predicts successful discontinuation of renal therapy in critically ill patients with acute ...

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study. Read more.

Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Novartis has claimed the top spot in the 2024 Access to Medicine Index, displacing GSK after 16 consecutive years at the top.